Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MDA passes on J lead advice to UK doctors:

This article was originally published in Clinica

Executive Summary

The UK device regulator has recommended that patients implanted with Telectronics' Accufix atrial J pacemaker leads should now consider leaving them in place. The Medical Devices Agency (MDA) gave this advice to UK surgeons managing patients with the faulty leads based on advice from the Accufix Research Institute. The institute, set up in the wake of the Telectronics J lead adverse incidents in 1994, suggested in a "dear doctor" letter in November that surgeons should consider the age of the patient when considering a potentially life-threatening procedure to remove the leads. The J leads were taken off the market after lead fracture, with protrusion of the retention wire.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069772

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel